NCT04874480 2026-01-09Tegavivint for the Treatment of Relapsed or Refractory LeukemiaM.D. Anderson Cancer CenterPhase 1 Active not recruiting9 enrolled
NCT03904251 2023-11-18CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid LeukemiaJonsson Comprehensive Cancer CenterPhase 1 Terminated13 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled